Dr Reddy's shares up 5% on US FDA OK

Shares in drug maker Dr Reddy's Laboratories rose over 5 percent early in the day on a likely US FDA approval for its drug, two dealers said.

At 10.41 a.m. shares were at 1,594 rupees, up 3.29 percent, but off its high of 1,622.95 rupees, out of breath after the company said it has received U.S. FDA approval for its fondaparinux sodium injection and will also manufacture fondaparinux under license using a patented process developed by Alchemia Ltd.

Company INFO

More on Dr Reddy's Laboratories

Stocks

More on Dr Reddy's Laboratories

Please read our terms of use before posting comments
TERMS OF USE: The views expressed in comments published on indianexpress.com are those of the comment writer's alone. They do not represent the views or opinions of The Indian Express Group or its staff. Comments are automatically posted live; however, indianexpress.com reserves the right to take it down at any time. We also reserve the right not to publish comments that are abusive, obscene, inflammatory, derogatory or defamatory.